Keywords: Bladder carcinoma; Cystectomy; Sexual function preserving; Prostate sparing; Neobladder; BC; bladder cancer; BCG; bacillus Calmette-Guérin; CSM; Cancer specific mortality; CSS; Cancer specific survival; CIS; carcinoma in situ; CIC; clean intermittent cat
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: urinary bladder neoplasms; hematuria; pathology; molecular; RNA; messenger; early detection of cancer; ABL1; ABL proto-oncogene 1; ANXA10; annexin 10; BCa; bladder cancer; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CRH; corticotropin releasin
Keywords: MANOVA; multivariate analysis of variance; Glc; glucose; Fru; fructose; Sac; saccharose (sucrose); Tre; trehalose; Mal; maltose; Ara; arabinose; Tur; turanose; Rib; ribose; Gent; gentiobiose; Ism; isomaltose; Pan; panose; Ismt; isomaltotriose; Malt; malto
Keywords: AMI; Advanced Metering Infrastructure; ANSI; American National Standards Institute; ASHRAE; American Society of Heating, Refrigeration, and Air Conditioning Engineers; CCC; California Commissioning Collective; CDM; Clean Development Mechanism; CFL; Compac
Keywords: European regulation model; HMP; EU monograph; TUR; WEU-MA; ESCOP; European Scientific Cooperative on Phytotherapy; WHO; World Health Organization; EU; European Union; HMPs; herbal medicinal products; WEU-MAs; marketing authorizations; TURs; traditional us
Keywords: prostatic hyperplasia; transurethral resection of prostate; comparative effectiveness research; BOO; bladder outlet obstruction; BPH; benign prostatic hyperplasia; bTURP; bipolar transurethral resection of the prostate; GL-PVP; GreenLight photovaporizatio
Keywords: BCG vaccine; cancer vaccines; cell cycle checkpoints; immunotherapy; urologic neoplasms; AE; adverse event; APC; antigen presenting cell; BCG; bacillus Calmette-Guérin; CAR; chimeric antigen receptor; CIS; carcinoma in situ; CTA; cancer testis antigen; C
Keywords: urinary bladder neoplasms; drug therapy; neoplasm recurrence; local; guideline adherence; practice patterns; physicians'; IPIOC; immediate postoperative instillation of chemotherapy; NMIBC; nonmuscle invasive bladder cancer; TUR; transurethral resection
Keywords: urinary bladder neoplasms; cystectomy; neoplasm recurrence; local; patient selection; morbidity; BCa; bladder cancer; BCG; bacillus Calmette-Guérin; CG; Clavien grade; CIS; carcinoma in situ; DSS; disease specific survival; LVI; lymphovascular invasion;
Keywords: watchful waiting; urinary bladder neoplasms; risk assessment; BCa; bladder cancer; TUR; transurethral resection;
Keywords: Nonmuscle invasive bladder cancer; High-risk bladder cancer; High-grade T1; HGT1; Carcinoma in situ; CIS; TUR; reTUR;
Keywords: urinary bladder neoplasms; cautery; artifacts; obturator nerve; intraoperative complications; CONSORT; Consolidated Standards of Reporting Trials; TUR; transurethral resection; TURBT; bladder tumor TUR;
Keywords: DCP; decentralised procedure; Eur. Com.; European Commission; EDQM; European Directorate for Quality of Medicines; EFTA; The European Free Trade Association; EMA; European Medicines Agency; EU; European Union; HMP; herbal medicinal product(s); HMPC; Commi
Keywords: BTF; bladder tumor fibronectin; CI; confidence interval; AUC; area under the summary ROC curve; TUR; transurethral resection; QUADAS; quality assessment of diagnostic accuracy studies; PLR; positive likelihood ratio; NLR; negative likelihood ratio; SROC;
The challenges of Bacillus of Calmette-Guerin (BCG) therapy for high risk non muscle invasive bladder cancer treatment in older patients
Keywords: BC; bladder cancer; NMIBC; non muscle invasive bladder cancer; MIBC; muscle invasive bladder cancer; EAU; European association of urology; EORTC; European Organisation for Research and Treatment of Cancer.; TUR; trans-urethral resection; BCG; Bacillus of
Predicting the tumorigenic phenotype of human bladder cancer cells by combining with fetal rat mesenchyme
Keywords: Invasive bladder cancer; Responsiveness of cancer cells to stroma; Fetal mesenchyme; Micropapillary-like structures; p63 isoforms; BLM; bladder mesenchyme; CIS; carcinoma in situ; EMT; epithelial-mesenchymal transition; H&E; hematoxylin and eosin; MIBC; m
Active Surveillance for Low Risk Nonmuscle Invasive Bladder Cancer: A Confirmatory and Resource Consumption Study from the BIAS Project
Keywords: urinary bladder neoplasms; neoplasm invasiveness; watchful waiting; risk; cost-benefit analysis; AS; active surveillance; IOF; in-office fulguration; LG; low grade; MIBC; muscle invasive bladder cancer; NMIBC; nonMIBC; TUR; transurethral resection; TURBT;
OncologyMetastatic Melanoma to the Bladder: Case Report and Review of the Literature
Keywords: Bladder; Melanoma; Cystectomy; Metastatic; CT; computed tomography; MRI; magnetic resonance imaging; TURBT; transurethral resection of bladder tumor; TUR; transurethral resection; SBRT; stereotactic body radiation therapy;
Original articleOutcome analysis of transrectal ultrasonography guided aspiration versus transurethral resection of prostatic abscess: 10Â years' experience from a tertiary care hospital
Keywords: CKD; chronic kidney disease; TUR; transurethral resection; Prostatic abscess; Transrectal aspiration; Transurethral resection; Transurethral deroofing;
Recurrent bladder tumors after transurethral resection: Diagnostic yield of MDCT-virtual cystoscopy
Keywords: Cystoscopy; Virtual; CT; Recurrent bladder carcinoma; Conventional; CC; conventional cystoscopy; 3D; three-dimensional; MDCT; multidetector computed tomography; CT-VC; , computed tomographyvirtual cystoscopy; MPR; multiplanar reconstruction; TUR; transure
Research articleDiagnostic performance of MRI for prediction of muscle-invasiveness of bladder cancer: A systematic review and meta-analysis
Keywords: MIBC; muscle-invasive bladder cancer; TUR; transurethral resection; MRI; magnetic resonance imaging; T1WI; T1-weighted imaging; T2WI; T2-weighted imaging; CE; contrast-enhanced; DWI; diffusion-weighted imaging; PRISMA; Preferred Reporting Items for System
Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5α-Reductase Inhibitor
Keywords: bladder neoplasms; neoplasm recurrence; local; androgen antagonists; prevention and control; 5-alpha reductase inhibitors; ADT; androgen deprivation therapy; AR; androgen receptor; AST; androgen suppression therapy; BCG; bacillus Calmette-Guérin; BPH; be
The Timing of Radical Cystectomy for bacillus Calmette-Guérin Failure: Comparison of Outcomes and Risk Factors for Prognosis
Keywords: urinary bladder neoplasms; BCG vaccine; treatment failure; cystectomy; mortality; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CSS; cancer specific survival; HG; high grade; IFN; interferon; IVT; intravesical therapy; LVI; lymphovascular invasi
TaG1 Bladder Cancer: A Third of All Primary Tumors and 80% of All Recurrences Can Be Treated in the Office Using Local Anesthesia
Keywords: urinary bladder neoplasms; neoplasm recurrence; local; cystoscopy; anesthesia; physicians' offices; GA; general anesthesia; LA; local anesthesia; NMIBC; nonmuscle invasive bladder cancer; OR; operating room; TUR; transurethral resection;
The Sensitivity of Initial Transurethral Resection or Biopsy of Bladder Tumor(s) for Detecting Bladder Cancer Variants on Radical Cystectomy
Keywords: urinary bladder; urothelium; carcinoma; cystectomy; neoplasm aggressiveness; RC; radical cystectomy; TUR; transurethral resection; TURB; bladder TUR; UC; urothelial carcinoma;
SWOG S0353: Phase II Trial of Intravesical Gemcitabine in Patients with Nonmuscle Invasive Bladder Cancer and Recurrence after 2 Prior Courses of Intravesical Bacillus Calmette-Guérin
Keywords: urinary bladder neoplasms; administration; intravesical; gemcitabine; neoplasm invasiveness; BCG; bacillus Calmette-Guérin; CIS; carcinoma in situ; CR; complete response; MMC; mitomycin C; RFS; recurrence-free survival; TUR; transurethral resection;
Off-label Prescriptions: how to Identify Them, Frame Them, Announce Them and Monitor Them in Practice?
Keywords: MA; off-MA; conditonal MA; temporary treatment protocol; regulation; temporary use recommendations; Afssaps; French Agency for the Safety and Health Products (Agence française de sécurité sanitaire des produits de santé); ANSM; National Security Agenc
European Association of Urology Guidelines on Laser Technologies
Keywords: BPH; BPO; BPE; Laser therapy; KTP PVP; LBO PVP; TURP; TUR; Ho:YAG; Tm:YAG; Prostate cancer; Bladder cancer; Nephrectomy; Endoscopy; Laparoscopy; Endoureterectomy; UPJ obstruction; UUT; Stones; Photoselective vaporisation; EAU; GuidelinesHBP; OPB; ABP; Tra
Proteomic tissue profiling for the improvement of grading of noninvasive papillary urothelial neoplasia
Keywords: CI; confidence interval; HG; high grade; IMS; imaging mass spectrometry; LG; low grade; MALDI TOF; Matrix Assisted Laser Desorption/Ionization Time Of Flight; PWKW; P-value of Wilcoxon or Kruskal-Wallis test; ROI; region of interest; SVM; Support Vector
National Practice Patterns for Immediate Postoperative Instillation of Chemotherapy in Nonmuscle Invasive Bladder Cancer
Keywords: urinary bladder neoplasms; drug therapy; administration, intravesical; physician's practice patterns; urology; AUA; American Urological Association; CIS; carcinoma in situ; IPOC; intravesical postoperative chemotherapy; IPOIC; immediate postoperative inst
Use of Fluorescence In Situ Hybridization to Predict Response to Bacillus Calmette-Guérin Therapy for Bladder Cancer: Results of a Prospective Trial
Keywords: urinary bladder neoplasms; mycobacterium bovis; in situ hybridization; fluorescence; treatment outcome; prognosisBCG, bacillus Calmette-Guérin; CIS, carcinoma in situ; FISH, fluorescence in situ hybridization; NMIBC, nonmuscle invasive bladder cancer; TUR
EAU Guidelines on Laser Technologies
Keywords: BPH; BPO; BPE; Laser therapy; KTP PVP; LBO PVP; TURP; TUR; Ho:YAG; Tm:YAG; Prostate cancer; Bladder cancer; Nephrectomy; Endoscopy; Laparoscopy; Endoureterectomy; UPJ obstruction; UUT; Stones; Photoselective vaporisation; EAU; Guidelines
Is 'second-look' (re-staging) transurethral resection of bladder tumours a new standard of care?
Keywords: TUR; transurethral resection; NMIBC; nonmuscle-invasive bladder cancer;
Clinical Predictive Factors of Poor Outcome in Patients With Stage pT0 Disease at Radical Cystectomy
Keywords: urinary bladder; cystectomy; neoplasm staging; neoplasm metastasis; prognosis; CIS; carcinoma in situ; DSS; disease specific survival; IC; induction chemotherapy; LVI; lymphovascular invasion; MIT; muscle invasive tumor; NMID; nonmuscle invasive disease;
Functional Detrusor Myoplasty for Bladder Acontractility: Long-Term Results
Keywords: motor neuron disease; urinary bladder; neurogenic; treatment outcomeBCI, bladder contractility index; CIC, clean intermittent catheterization; LDDM, latissimus dorsi detrusor myoplasty; PVR, post-void residual urine volume; Qmax, maximum uroflow rate; TUR
Modern transurethral resection in the management of superficial bladder tumours
Keywords: Transurethral resection; TUR; Bladder tumour; Resection; Superficial bladder cancer;
Myopodin Methylation is Associated With Clinical Outcome in Patients With T1G3 Bladder Cancer
Keywords: urinary bladder; urinary bladder neoplasms; Mycobacterium bovis; SYNPO2 protein; human; methylation; BCG; bacillus Calmette-Guerin; CIS; carcinoma in situ; MMC; mitomycin C; NED; no evidence of disease; TUR; transurethral resection;
Photodynamic Diagnosis in Non–Muscle-Invasive Bladder Cancer: A Systematic Review and Cumulative Analysis of Prospective Studies
Keywords: 5-ALA; Bladder neoplasms; Bladder cancer; HAL; Hexaminolevulinate; Meta-analysis; PDD; Transurethral resection; TUR; 5-aminolevulinic acid
Lymphovascular Invasion in Transurethral Resection Specimens as Predictor of Progression and Metastasis in Patients With Newly Diagnosed T1 Bladder Urothelial Cancer
Keywords: urinary bladder; carcinoma; transitional cell; lymphatic metastasis; neoplasm invasiveness; urothelium; LVI; lymphovascular invasion; TUR; transurethral resection; TURBT; TUR of bladder tumor;
An Analysis of the Effect of Statin Use on the Efficacy of Bacillus Calmette-Guerin Treatment for Transitional Cell Carcinoma of the Bladder
Keywords: carcinoma; transitional cell; mycobacterium bovis; immunotherapy; BCG; bacillus Calmette-Guerin; GTP; guanosine triphosphate; HMG-CoA; 3-hydroxy-3-methylglutaryl coenzyme A; TCC; transitional cell carcinoma; TUR; transurethral resection;
Holmium Laser Enucleation of the Prostate-Outcomes Independent of Prostate Size?
Keywords: prostate; prostatic hyperplasia; lasers, solid-state; prostatectomy; organ size; AUA; American Urological Association; AUA-SS; AUA symptom score; BPH; benign prostatic hyperplasia; HoLEP; holmium laser enucleation of the prostate; OP; open prostatectomy;
A Single Instillation of Epirubicin After Transurethral Resection of Bladder Tumors Prevents Only Small Recurrences
Keywords: bladder; bladder neoplasms; neoplasm recurrence; local; administration; intravesical; epirubicin; BCG; bacillus Calmette-Guerin; TUR; transurethral resection;
Prevention of Recurrence With Epirubicin and Lactobacillus Casei After Transurethral Resection of Bladder Cancer
Keywords: bladder; bladder neoplasms; neoplasm recurrence, local; epirubicin; Lactobacillus casei; BCG; bacillus Calmette-Guerin; EPI-ADM; epirubicin; LC; Lactobacillus casei; TUR; transurethral resection;
The Frequency of Hydronephrosis at Initial Diagnosis and its Effect on Recurrence and Progression in Patients With Superficial Bladder Cancer
Keywords: bladder; bladder neoplasms; prognosis; hydronephrosis; carcinoma; transitional cell; CIS; carcinoma in situ; CT; computerized tomography of abdomen and pelvis; IVP; excretory urogram; TCC; transitional cell carcinoma; TUR; transurethral resection; US; ult
A Randomized Trial of Radical Radiotherapy for the Management of pT1G3 NXM0 Transitional Cell Carcinoma of the Bladder
Keywords: urinary bladder neoplasms; randomized controlled trials; radiotherapy; BCG; bacillus Calmette-Guerin; CIS; carcinoma in situ; IDMC; Independent Data Monitoring Committee; MMC; mitomycin C; MRC; Medical Research Council; QLQ; quality of life questionnaire;
Predictive Value of N-Acetylglucosaminyltransferase-V for Superficial Bladder Cancer Recurrence
Keywords: bladder; bladder neoplasms; tumor marker; biological; recurrence; N-acetylglucosaminyltransferases; GnT-V; N-acetylglucosaminyltransferase-V; TUR; transurethral resection;
Chemoprevention for Bladder Cancer
Keywords: bladder; bladder neoplasms; carcinoma; transitional cell; chemoprevention; vitamins; ATBC; α-tocopherol β-carotene; BBN; N-butyl-N-(4-hydroxybutyl)nitrosamine; BC; bladder cancer; BCG; bacillus Calmette-Guerin; COX; cyclooxygenase; CPS; Cancer Preventio
Overexpression of laminin-5 γ2 chain and its prognostic significance in urothelial carcinoma of urinary bladder: association with expression of cyclooxygenase 2, epidermal growth factor, and human epidermal growth factor 2
Keywords: UC; urothelial carcinoma; TCC; transitional cell carcinoma; TUR; transurethral resection; LN; laminin; COX; cyclooxygenase; EGFR; epidermal growth factor receptor; HER; human EGFR; Urothelial carcinoma; Urinary bladder; Laminin-5; COX-2; erbB;